Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center.

Bobby, Lauren; Westlake, Evan; Esplin, Nathan; Young, Sarah

Bobby, Lauren; Westlake, Evan; Esplin, Nathan; Young, Sarah.

Afiliación

Bobby L; Department of Pharmacy, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212, United States of America. Electronic address: Lauren.bobby@ahn.org.
Westlake E; Department of Pharmacy, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212, United States of America.
Esplin N; Department of Neurosurgery, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212, United States of America.
Young S; Department of Pharmacy, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212, United States of America.

Thromb Res ; 206: 33-35, 2021 Oct.

Article en En | MEDLINE | ID: mdl-34399122

Asunto(s)

Inhibidores del Factor Xa; Centros Traumatológicos; Factores de Coagulación Sanguínea; Factor VIIa; Factor Xa; Inhibidores del Factor Xa/uso terapéutico; Humanos; Proteínas Recombinantes; Rivaroxabán

Palabras clave

Activated prothrombin complex concentrate (aPCC); Andexanet alfa; Apixaban; Intracranial hemorrhage (ICH); Reversal; Rivaroxaban

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Centros Traumatológicos / Inhibidores del Factor Xa Límite: Humans Idioma: En Revista: Thromb Res Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google